Alzheimer's disease is the most common type of dementia. Here, we break down what to know about this disease, including: What ...

Zunveyl, an oral medication, is a better-tolerated version of galantamine for managing mild to moderate Alzheimer's symptoms.

A University of the Basque Country (UPV/EHU) study proves that the WIN55.212-2 drug protects the brain and reverses the ...

How Dementia Affects the Brain's ... Huntington's disease (HD), according to a new ... 'Alzheimer's in Dish' Model Shows Promise for Accelerating Drug Discovery Nov. 27, 2024 — A decade ago ...

Effectively treating and preventing this common form of dementia will require a cocktail of drugs and a combination of ...

This class of drugs was associated with a 20% lower ... please read studies about vitamin D deficiency linked to Alzheimer’s and vascular dementia, and extra-virgin olive oil could boost brain ...

Nearly 7 million Americans have been diagnosed with dementia, which slowly erodes memory, thinking skills and the ability to ...

Use of the treatment has soared in popularity in recent years now taken by 2.6million women in England according to the ...

New research suggests that the risk for developing dementia is significantly higher than previously estimated, and the burden ...

The drug is aimed at treating mild cognitive impairment or mild to moderate dementia caused by Alzheimer's disease. We expect to hear whether the MHRA will approve this drug by the end of 2025. There ...

However, the type and amount of sleep medication used could ... than white individuals to develop Alzheimer’s disease, the most common form of dementia. These studies have also suggested that ...

(“Alpha”) of the improved new drug ZUNVEYL（benzgalantamine delayed-release tablets）(“ZUNVEY” or the “Product”) for the treatment of mild-to-moderate dementia of the Alzheimer’s ty ...